Cargando…
Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
The use of biomarkers in medicine lies in their ability to detect disease and support diagnostic and therapeutic decisions. New research and novel understanding of the molecular basis of the disease reveals an abundance of exciting new biomarkers who present a promise for use in the everyday clinica...
Autores principales: | Tzouvelekis, Argyris, Pneumatikos, Ioannis, Bouros, Demosthenes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168906/ https://www.ncbi.nlm.nih.gov/pubmed/15972108 http://dx.doi.org/10.1186/1465-9921-6-62 |
Ejemplares similares
-
Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005) -
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome
por: Bouros, Demosthenes, et al.
Publicado: (2004) -
Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006) -
Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004) -
Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)